PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.190
-0.090 (-7.03%)
At close: Dec 5, 2025, 4:00 PM EST
1.220
+0.030 (2.52%)
After-hours: Dec 5, 2025, 7:01 PM EST
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $63.32 million as of December 5, 2025. Its market cap has decreased by -21.56% in one year.
Market Cap
63.32M
Enterprise Value
-62.87M
1-Year Change
-21.56%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $63.32M, a decrease of -96.07%. That is a compound annual growth rate of -46.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 68.11M | -12.83% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |